Enterovirus D68 (EV-D68) belongs to the family *Picornaviridae*, genus *Enterovirus*, species *Enterovirus D*. Since its initial discovery in 1962 ([@R1]), EV-D68 infections in humans have been reported rarely. However, since 2008, clusters of acute respiratory infections (ARIs) associated with EV-D68 have been reported worldwide, including Europe ([@R2]--[@R5]).

During mid-August 2014--January 2015, the United States and Canada had nationwide outbreaks of EV-D68 infections associated with severe respiratory disease ([@R6],[@R7]). The US Centers for Disease Control and Prevention and state public health laboratories confirmed 1,153 persons in 49 states and the District of Columbia infected by EV-D68 ([@R8]). Over the same period, \>200 specimens tested were positive for EV-D68 throughout Canada ([@R7]). Clinical symptoms ranged from mild to severe disease requiring intensive care and mechanical ventilation. Children were predominantly affected, in particular if they had asthma or wheezing ([@R6],[@R9]). After ARIs, symptoms of neurologic illness or acute flaccid myelitis developed in an increasing number of children ([@R10],[@R11]).

To describe EV-D68 circulation in a large country in Europe in the fall of 2014, we investigated specimens from patients with respiratory illness for EV-D68. This investigation was conducted within the national outpatient ARI sentinel surveillance in Germany.

The Study
=========

Nasal swab specimens from outpatients with influenza-like illness (ILI), ARI, or both were collected by sentinel physicians participating in sentinel surveillance in Germany during weeks 32--44 in 2014 and sent to the Robert Koch Institute (Berlin, Germany). All specimens were tested in parallel for respiratory viruses, including influenza viruses A and B, rhinovirus/enterovirus, respiratory syncytial virus, adenovirus, and metapneumovirus by specific real-time reverse transcription PCRs ([Technical Appendix](#SD1){ref-type="local-data"}). The rhinovirus/enterovirus real-time PCR detected rhinovirus at a limit of detection of 26 copies/reaction. EV-D68 was identified at a slightly lower sensitivity of 118 copies/reaction.

Rhinovirus/enterovirus--positive specimens were screened for EV-D68 by sequencing the viral protein (VP) 4/VP2 gene regions. Rhinovirus/enterovirus--negative specimens and samples without sequencing results were additionally analyzed by using a specific EV-D68 PCR ([@R12]). VP4/VP2 and VP1 regions were sequenced (GenBank accession nos. KP189380--KP189403 and KP657730--KP657747) for EV-D68--positive specimens.

Rhinovirus/enterovirus was detected in 44% (143/325) of the specimens; 98 were identified as rhinovirus types A--C and 25 as EV-D68. The remaining 20 specimens could not be subtyped, but were negative for EV-D68 by using the specific PCR. The proportion of EV-D68 corresponded to 7.7% of the study collective. EV-D68 was initially detected from week 36 (August) through 38 (September) and continuously from week 41 through week 44 in October ([Figure 1](#F1){ref-type="fig"}).
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In addition to the other viruses tested, EV-D68--positive specimens were screened for parainfluenza virus 1--4, coronaviruses (NL63, OC43, HKU1, 229E), and bocavirus. None of these viruses was detected in EV-D68--positive patients, which suggested that EV-D68 played a major role in causing respiratory disease.

Major symptoms associated with EV-D68 infection included sudden onset, fever/shivers, cough, and sore throat ([Table 1](#T1){ref-type="table"}). Pneumonia was diagnosed in a 7-year-old boy and a 10-year-old girl, and a 2-year-old girl was hospitalized because of obstructive bronchitis. For 11 (44%) of 25 case-patients, a concurrent chronic condition was reported: 5 with a respiratory condition, 3 with a cardiac condition, 2 with diabetes, and 1 with a neurologic disorder. EV-D68 was detected in 10 children and 15 adults; 56% of these patients were male.

###### Demographic and clinical characteristics of 25 patients infected with enterovirus D68, Germany, weeks 32--44, 2014\*

  Patient   Week†   Age, y/sex   Federal state            Sudden onset of disease   Fever/shivers   Cough   Sore throat   Clinical follow-up       Admission to hospital   Underlying condition
  --------- ------- ------------ ------------------------ ------------------------- --------------- ------- ------------- ------------------------ ----------------------- ------------------------------
  1         36      6/F          Thuringia                \+                        \+              \+      \+            ILI                      No                      None
  2         36      42/M         North Rhine-Westphalia   \+                        \+              \+      \+            ILI                      No                      Respiratory system
  3         37      61/M         North Rhine-Westphalia   \+                        \+              \+      \+            ILI                      No                      Cardiac system
  4         37      42/F         North Rhine-Westphalia   --                        \+              \+      \+            ARI                      No                      Respiratory system
  5         38      11/M         Thuringia                \+                        \+              \+      \+            ILI                      No                      None
  6         40      35/F         Lower Saxony             \+                        \+              \+      --            ILI                      No                      Respiratory system, diabetes
  7         40      53/M         North Rhine-Westphalia   \+                        \+              \+      \+            ILI                      No                      Cardiac system
  8         41      2/M          Thuringia                \+                        \+              \+      --            ILI                      No                      None
  9         41      62/M         Hesse                    \+                        --              \+      \+            ARI                      No                      None
  10        41      7/M          Rheinland-Palatinate     \+                        \+              \+      \+            Pneumonia                No                      Respiratory system
  11        42      8/F          Bavaria                  NA                        NA              \+      \+            ARI                      No                      None
  12        42      25/M         Hesse                    \+                        --              \+      --            ARI                      No                      None
  13        42      22/M         Lower Saxony             \+                        \+              \+      \+            ILI                      No                      None
  14        42      14/F         Baden-Württemberg        --                        --              \+      \+            ARI                      No                      None
  15        42      43/M         Bavaria                  \+                        --              \+      \+            ARI                      No                      None
  16        42      10/F         Berlin                   --                        \+              \+      \+            Broncheal pneumonia      No                      Respiratory system
  17        43      3/F          North Rhine-Westphalia   \+                        \+              \+      --            ILI                      No                      None
  18        43      12/F         Bavaria                  \+                        --              \+      \+            ARI                      No                      None
  19        43      52/M         Lower Saxony             \+                        \+              \+      \+            ILI                      No                      Diabetes
  20        43      26/M         North Rhine-Westphalia   \+                        \+              \+      --            ILI                      No                      None
  21        43      44/M         North Rhine-Westphalia   \+                        --              \+      \+            ARI                      No                      Cardiac system
  22        43      2/F          Hesse                    \+                        \+              \+      --            Obstructive bronchitis   Yes                     None
  23        43      41/M         Saarland                 \+                        \+              \+      \+            ILI                      No                      None
  24        44      2/F          Schleswig-Holstein       \+                        --              \+      --            ARI                      No                      None
  25        44      73/F         North Rhine-Westphalia   --                        --              \+      \+            ARI                      No                      Neurologic disorder

\*+, positive; ILI, influenza-like illness; --, negative; ARI, acute respiratory infection; NA, not available. †Data are listed by week of symptom onset.

Patients infected with EV-D68 came from different federal states in Germany; no epidemic cluster or outbreak was detected in the context of these patients. Syndromic surveillance data of corresponding sentinel practices showed only a partial coincidence of EV-D68--positive patients and an increase of ARI activity in the practice. However, the increase in ARI activity was probably caused by unrelated RV activity.

Sequence analysis is not regularly performed for rhinovirus/enterovirus--positive specimens within sentinel surveillance in Germany. However, comparative data can be provided for week 36 through week 20 for the 2009--10 and 2010--11 seasons ([Table 2](#T2){ref-type="table"}). During those seasons, patients with ILI in 5 age groups (\<1--4, 5--15, 16--34, 35--60, and \>60 years) were investigated by using the rhinovirus/enterovirus real-time reverse transcription PCR. Within the seasons, an average of 21% (198/952 for 2009--10) and 13% (128/1002 for 2010--11) of specimens were positive for rhinovirus/enterovirus ([Table 2](#T2){ref-type="table"}). At least 20% of the rhinovirus/enterovirus--positive specimens were arbitrarily chosen for sequencing (mainly RV A, B, or C; 1 echovirus), but no EV-D68 was identified.

###### Detection of rhinovirus and enterovirus by national outpatient ARI sentinel surveillance, Germany, weeks 36--20, 2009--2010 and 2010--2011\*

  Age group, y   No. specimens tested   No. rhinovirus/enterovirus--positive specimens (%)   No. rhinoviruses/enteroviruses sequenced   No. rhinoviruses detected   No. enteroviruses detected
  -------------- ---------------------- ---------------------------------------------------- ------------------------------------------ --------------------------- ----------------------------
  2009--2010                                                                                                                                                        
  \<1--4         156                    45 (29)                                              11                                         11                          0
  5--15          386                    71 (18)                                              18                                         17                          1†
  16--34         225                    40 (18)                                              12                                         12                          0
  35--60         157                    34 (22)                                              19                                         19                          0
  \>60           28                     8 (29)                                               4                                          4                           0
  Total          952                    198 (21)                                             64                                         63                          1
  2010--2011                                                                                                                                                        
  \<1--4         271                    56 (21)                                              21                                         21                          0
  5--15          363                    40 (11)                                              20                                         20                          0
  16--34         189                    20 (11)                                              17                                         17                          0
  35--60         153                    12 (9)                                               11                                         11                          0
  \>60           26                     0 (0)                                                0                                          0                           0
  Total          1,002                  128 (13)                                             69                                         69                          0

\*ARI acute respiratory infection.  †Echovirus 9.

Phylogenetic analysis of EV-D68 strains detected in Germany was conducted for the VP1 and the VP4/VP2 genomic regions ([Figure 2](#F2){ref-type="fig"}). Analysis placed EV-D68 isolates from Germany into major groups 1 or 3 and clustered with strains from the United States and the Netherlands from 2014, which indicated circulation of similar strains in the United States and Europe.
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Conclusions
===========

In the 2014 outbreak in the United States, ≈36% (2,600) of specimens were positive for EV-D68; children were predominantly affected. Because testing was prioritized for children with severe respiratory illness, there were probably more cases of mild infections ([@R8]). Information on EV-D68 circulation during this period for Europe is rare. This finding might be caused by insufficient sampling of patients with ARI or limited detection of EV-D68 by laboratory diagnostics ([@R9]). Sporadic cases of neurologic disease after EV-D68 infection were reported from France and the United Kingdom ([@R9],[@R10]).

Investigation for EV-D68 has been continuously performed in the Netherlands since the increase in infections in 2010 ([@R13]). The ILI/ARI sentinel system in the Netherlands identified 24 EV-D68 infections in 2010, none in 2011, 7 in 2012, 3 in 2013, and 5 in 2014 (by week 40) ([@R13],[@R14]), which probably increased toward the end of that year ([@R9]). For the 2014 season, a hospital in the Netherlands reported an increase of EV-D68; 16 patients were infected ([@R12]). Such an increase in EV-D68 infections was already seen in 2010 at the same hospital along with an increased number of cases throughout the country ([@R13]). This finding increased the possibility that an increase in EV-D68 infections in primary care will also extend to increased numbers of infections in patients in secondary care. So far, we report low EV-D68 circulation in Germany: 25 sporadic cases in 2014.

Clinical patterns in patients in Germany were largely determined by the ILI/ARI case definition for collecting specimens. Most (88%) patients had mild disease. Severe disease was observed in 3 children who had obstructive bronchitis and pneumonia, and 1 child required hospital care. Similarly, mild respiratory disease was predominantly observed for patients in the Netherlands ([@R14]). However, more severe cases were detected among hospitalized children who had life-threatening respiratory illness, as described in the United States ([@R6],[@R12],[@R14]). More than half of patients with severe respiratory illness in Germany and the Netherlands had concurrent conditions ([@R12],[@R14]), which seem to be a major factor for development of severe disease after EV-D68 infection ([@R6]).

Phylogenetic analysis of EV-D68 from Germany showed high similarity with current strains from the United States and the Netherlands ([@R12],[@R14]). These new genetic clusters reflect the evolution of EV-D68 and might be associated with an increasing activity of this virus. For an improved understanding of the factors determining local and temporal differences in respiratory disease outbreaks, continuous collection of global data by representative surveillance systems is needed.

###### 

**Technical Appendix.** Supplemental methods used for detection of enterovirus D68--associated acute respiratory infections, Germany, 2014.
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